Organization · Venture Capital
OCV
OCV Partners is a Los Angeles-based venture capital firm that invests in startups with differentiated technologies in the technology and healthcare sectors. The firm leverages its extensive expertise to support founders in creating value.
Overview
What OCV does
What OCV is
OCV Partners is a Los Angeles-based venture capital firm that invests in startups with differentiated technologies in the technology and healthcare sectors. The firm leverages its extensive expertise to support founders in creating value.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 26, 2026
Official channels
Find OCV elsewhere
Open the official website or a supported primary organization account.
Capability profile
OCV as a funder
Investment thesis
Partner with exceptional founders building differentiated technology in compelling target markets; create asymmetric advantages.
Focus narrative
OCV Partners focuses on investing in two primary sectors: Technology and Healthcare. In Technology, they invest in Software as a Service (SaaS), FinTech, and PropTech, seeking subscription software and recurring revenue business models. In Healthcare, they support entrepreneurs developing disruptive platforms in Healthcare SaaS, Digital Health, MedTech, and Biotech to improve patient lives and optimize treatment decisions.
Value beyond capital
OCV Partners leverages its diverse expertise and extensive network to support portfolio companies in scaling their operations, optimizing their business models, and navigating the complexities of their respective markets.
Terms and economics
- Typical check
- $1,000,000
- Sweet spot
- $70,000,000
Focus and fit
- Stages
- Series A · Series B · Growth Equity
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: 1200 Pharma (oncology therapeutics), ByHeart (infant nutrition), Figure 8 (experience-first development), Finch Therapeutics (microbiome therapies), Invoice2go (mobile app for small businesses), Orca AI (marine collision avoidance), Rad AI (AI tools for radiology), SafeBreach (cybersecurity solutions), Social Native (branded content platform), and TechStyle Fashion Group (subscription fashion retailer).
Common questions
What to know about OCV
Upseed classifies OCV under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.